NM_175736.5(FMNL3):c.2251A>C (p.Ile751Leu) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jun 13, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004144982.1

Allele description [Variation Report for NM_175736.5(FMNL3):c.2251A>C (p.Ile751Leu)]

NM_175736.5(FMNL3):c.2251A>C (p.Ile751Leu)

Gene:

FMNL3:formin like 3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12q13.12

Genomic location:

Preferred name:

NM_175736.5(FMNL3):c.2251A>C (p.Ile751Leu)

HGVS:

NC_000012.12:g.49649523T>G
NM_001367835.1:c.2251A>C
NM_175736.5:c.2251A>CMANE SELECT
NM_198900.3:c.2098A>C
NP_001354764.1:p.Ile751Leu
NP_783863.4:p.Ile751Leu
NP_944489.2:p.Ile700Leu
NC_000012.11:g.50043306T>G
NM_175736.4:c.2251A>C

Protein change:

I700L

Molecular consequence:

NM_001367835.1:c.2251A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_175736.5:c.2251A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_198900.3:c.2098A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Mus musculus nuclear transport factor 2 (Nutf2), transcript variant 3, mRNA
Mus musculus nuclear transport factor 2 (Nutf2), transcript variant 3, mRNA
gi|1269208452|ref|NM_001357230.1|

Nucleotide
Chain A, Maltose/maltodextrin-binding periplasmic protein, NACHT, LRR and PYD do...
Chain A, Maltose/maltodextrin-binding periplasmic protein, NACHT, LRR and PYD domains-containing protein 6 chimera
gi|1562366880|pdb|6NDJ|A

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003629761	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jun 13, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003629761

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jun 13, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003629761.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.2251A>C (p.I751L) alteration is located in exon 19 (coding exon 19) of the FMNL3 gene. This alteration results from a A to C substitution at nucleotide position 2251, causing the isoleucine (I) at amino acid position 751 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 10, 2024

ClinVar

Relating variation to medicine